Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_assertion type Assertion NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_head.
- NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_assertion description "[Addiction to elevated insulin-like growth factor I receptor and initial modulation of the AKT pathway define the responsiveness of rhabdomyosarcoma to the targeting antibody.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_provenance.
- NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_assertion evidence source_evidence_literature NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_provenance.
- NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_assertion SIO_000772 18829562 NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_provenance.
- NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_assertion wasDerivedFrom befree-20140225 NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_provenance.
- NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_assertion wasGeneratedBy ECO_0000203 NP481978.RANX77_E80NHSeMuTr5sZLwyklf05WIVOv8evJTOeUvak130_provenance.